Page last updated: 2024-08-23

bezafibrate and Malignant Melanoma

bezafibrate has been researched along with Malignant Melanoma in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Bando, H; Hosoda, W; Matsubara, Y; Muro, K; Niwa, Y; Onishi, S; Tajika, M	1
Dellavalle, RP; Drake, AL; Freeman, SR; Graber, M; Heilig, LF; McNealy, K; Schilling, LM	1

Reviews

1 review(s) available for bezafibrate and Malignant Melanoma

Article	Year
Statins, fibrates, and melanoma risk: a systematic review and meta-analysis. Journal of the National Cancer Institute, 2006, Nov-01, Volume: 98, Issue:21 Topics: Atorvastatin; Bezafibrate; Clofibrate; Gemfibrozil; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Incidence; Lovastatin; Melanoma; Odds Ratio; Pravastatin; Pyrroles; Randomized Controlled Trials as Topic; Reproducibility of Results; Simvastatin; Skin Neoplasms; United States	2006

Article

Year

Statins, fibrates, and melanoma risk: a systematic review and meta-analysis.

Journal of the National Cancer Institute, 2006, Nov-01, Volume: 98, Issue:21

Topics: Atorvastatin; Bezafibrate; Clofibrate; Gemfibrozil; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Incidence; Lovastatin; Melanoma; Odds Ratio; Pravastatin; Pyrroles; Randomized Controlled Trials as Topic; Reproducibility of Results; Simvastatin; Skin Neoplasms; United States

2006

Other Studies

1 other study(ies) available for bezafibrate and Malignant Melanoma

Article	Year
Ursodeoxycholic acid and bezafibrate were useful for steroid-refractory, immune-related hepatitis: a case report. Journal of medical case reports, 2020, Nov-26, Volume: 14, Issue:1 Topics: Aged; Bezafibrate; Humans; Male; Melanoma; Nivolumab; Skin Neoplasms; Ursodeoxycholic Acid	2020